NCT03902028Completed
Optimized Medico-pharmaceutical Collaboration in the Drug Management of Patients With Heart Failure
Interest of an Optimized Medico-pharmaceutical Collaboration in the Drug Management of Patients With Heart Failure: Controlled, Randomized, Multicentric Study
Source: ClinicalTrials.gov · Last updated 3 Apr 2026
Brief summary (registry, in English)
This is a controlled, randomized, open-label, multicentric study evaluating the value of coordinated medico-pharmaceutical management compared to standard management in patients with heart failure. The aim of this study is to evaluate the impact of these optimized activities on the re-hospitalization of the patient with cardiac insufficiency for a disease-related event within three months of the initial hospitalization.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 229 (actual)
- First submitted
- 27 Mar 2019
- Start date
- 2 Aug 2019
- Primary completion date
- 25 Jan 2025
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Heart failure
- NCT number
- NCT03902028
What you commit to
- Study type: Interventional
- Participants enrolled: 229
- From 2 Aug 2019 to the primary completion date, 25 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Non autonomous drug management patients and not disposing
Other
- a present caregiver during hospitalisation
- Patients living in an institution
- Person participating in another clinical trial with an exclusion period still ongoing
- Person whose physical and/or psychological health is severely altered, and which, in the opinion of the investigator, may affect the participation's to the study
- Person deprived of his rights, person under tutorship or guardianship
- Refusal to sign the consent
Who the study is looking for
- Patient aged more than 18 years
- Adult patient admitted in cardiology department (full hospitalisation or intensive care) for heart failure no matter the type and the stage of the disease
- Person affiliated or beneficiary of a social security system
- Collection of a free, informed, express and written consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital of Montpellier Cardiology departments oh the Montpellier, Nîmes and Toulouse University Hospitals Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.